about
Challenges in translating endpoints from trials to observational cohort studies in oncologyThe Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer PatientsUse of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifenRegistration in the Danish Regional Nonmelanoma Skin Cancer Dermatology Database: completeness of registration and accuracy of key variables.Hospital recorded morbidity and breast cancer incidence: a nationwide population-based case-control study.CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.Missing data and multiple imputation in clinical epidemiological research.Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis.The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study.Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study.Autoimmune diseases and breast cancer recurrence: a Danish nationwide cohort study.Conization as a marker of persistent cervical human papillomavirus (HPV) infection and risk of gastrointestinal cancer: a Danish 34-year nationwide cohort study.Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007.Modification of tamoxifen response: what have we learned?Use of prescription drugs and risk of postoperative red blood cell transfusion in breast cancer patients: a Danish population-based cohort study.
P50
Q26746190-F4CC6C31-246F-4822-B3E5-02AC36AC2B7AQ26782449-E8E343C4-5EF1-4338-8B29-093235716210Q33526072-38DA7F6E-254F-449A-9F72-D4F6AFA83CB8Q33940729-11DC23ED-9F6B-4855-8DF6-AECF391C9CA6Q34144181-C49AC48A-BBD6-4040-BC5B-58B341E43F15Q34456305-14CE8566-8A0F-465D-8821-AC4FEBD068BFQ34677193-59750ECD-DE78-4E1A-8578-3CE6202D2540Q36326160-BCC6FEAF-A815-4148-9A18-3360D38F93DDQ37195016-CDAB3A69-4C0F-4E57-B04A-79B5DA8253CCQ37465305-A3465E48-6C67-4632-BB3A-6D9967590EF3Q40099998-76D2F474-A4CF-4DB0-8B0A-0ADF7959233AQ40148639-668DB50D-EB42-4326-8C04-5DBFA42450EAQ40157593-F64611F3-6BB0-4F19-AB3A-BF648BDFE2CBQ41630053-8FAECA99-8F24-45B6-803C-EC1EE04517D7Q41706167-9BCB69E6-D30F-4FE4-8177-EF56EEFD8F4BQ42581544-81BAD2A4-CDBB-4E74-A531-AE9340C13FB6Q43042856-232824AD-DC5A-4D18-8A1F-421320C2EE7CQ45023619-6ED565DC-B08D-41DE-A3D6-E599569F3B86Q46674502-7657C45B-0FC1-4338-91F7-9127E1A102C1Q47128677-88953002-5D6B-4917-AB64-A8B703FA0F1E
P50
name
Deirdre Cronin-Fenton
@ast
Deirdre Cronin-Fenton
@en
Deirdre Cronin-Fenton
@es
Deirdre Cronin-Fenton
@fr
Deirdre Cronin-Fenton
@nl
type
label
Deirdre Cronin-Fenton
@ast
Deirdre Cronin-Fenton
@en
Deirdre Cronin-Fenton
@es
Deirdre Cronin-Fenton
@fr
Deirdre Cronin-Fenton
@nl
prefLabel
Deirdre Cronin-Fenton
@ast
Deirdre Cronin-Fenton
@en
Deirdre Cronin-Fenton
@es
Deirdre Cronin-Fenton
@fr
Deirdre Cronin-Fenton
@nl